Foreword

Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors†

  1. Vernon E. Walker Special Issue Editor1,*,
  2. Miriam C. Poirier Special Issue Editor2,*

Article first published online: 14 MAR 2007

DOI: 10.1002/em.20296

Issue

Environmental and Molecular Mutagenesis

Environmental and Molecular Mutagenesis

Volume 48, Issue 3-4, pages 159–165, April - May 2007

Additional Information

How to Cite

Walker, V. E. and Poirier, M. C. (2007), Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environ. Mol. Mutagen., 48: 159–165. doi: 10.1002/em.20296

Author Information

  1. 1

    Lovelace Respiratory Research Institute, 2425 Ridgecrost Drive SE, Albuquerque, NM 87108

  2. 2

    Carcinogen-DNA Interactions Section, LCCTP, Bldg. 37 Room 4032, National Cancer Institute, NIH, 37 Convent Drive MSC-4255, Bethesda, MD 20892-4255

*Lovelace Respiratory Research Institute, 2425 Ridgecrost Drive SE, Albuquerque, NM 87108

  1. †

    Invited article on the genotoxicity of perinatal NRTI therapy.

Publication History

  1. Issue published online: 19 MAR 2007
  2. Article first published online: 14 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (113K)

First page of article

First page of Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors
Get PDF (113K)